Does Gout Get Worse With Age? What to Expect

Gout does get worse with age for most people, and the reasons go beyond simple wear and tear. Prevalence climbs steadily with each decade of life, peaking in the 60 to 69 age range globally. The biological forces driving this trend include declining kidney function, hormonal changes, accumulating joint damage, and the medications commonly prescribed for other age-related conditions. Understanding why gout worsens can help you manage it more effectively at every stage.

Why Uric Acid Levels Rise as You Age

The single biggest reason gout worsens with age is that your kidneys gradually lose their ability to flush uric acid out of your body. Your kidneys filter blood through tiny structures, and their filtering capacity naturally declines over time. A study published in Scientific Reports found that people with reduced kidney function were nearly four times more likely to have elevated uric acid levels compared to those with healthy kidney function (odds ratio of 3.82). When researchers adjusted their analysis to account for kidney decline, the link between older age and high uric acid essentially disappeared. In other words, it’s not aging itself that raises uric acid levels; it’s the kidney slowdown that comes with aging.

This means that by the time you reach your 60s or 70s, your body is simply less efficient at clearing uric acid, even if your diet and habits haven’t changed. The excess uric acid circulates in your blood and gradually crystallizes in your joints, triggering the painful inflammatory flares that define gout.

How Flares Change Over Time

Early gout typically strikes a single joint, most often the base of the big toe. Attacks come and go, sometimes with months or years of silence between them. Younger patients, generally those in their late 40s to early 50s, tend to experience fewer attacks per year.

As you age, the pattern shifts. Flares become more frequent and begin affecting joints beyond the big toe. Older adults more commonly experience gout in the knees, ankles, and wrists right from the start. Flares can also produce more systemic symptoms, including fever and general malaise, which can make gout harder to distinguish from infection or other conditions. The disease essentially broadens its footprint, involving more joints and producing more widespread inflammation.

The Path to Chronic Gout

Left untreated, gout follows a fairly predictable progression. The early stage of intermittent flares can evolve into chronic gout, where uric acid crystals form visible lumps called tophi under the skin and around joints. This transition typically takes about 10 years of recurrent attacks without adequate treatment. Tophi aren’t just cosmetic. They erode bone and narrow joint spaces, causing permanent structural damage that shows up clearly on X-rays.

Because this damage is cumulative, older patients who have lived with gout for decades face the greatest risk of joint destruction. Each untreated flare deposits more crystals, and each deposit chips away at the surrounding bone. Over time, this can limit your range of motion and make everyday tasks painful even between flares. The longer gout goes unmanaged, the harder it becomes to reverse the damage.

Menopause and Gout Risk in Women

Gout has long been seen as a condition that primarily affects men, and that’s true in younger age groups. But the gap narrows significantly after menopause. Estrogen promotes the excretion of uric acid through the kidneys and also has anti-inflammatory effects that help suppress the kind of immune response gout triggers. When estrogen levels drop during menopause, women lose both of these protective mechanisms.

A large population-based study of one million postmenopausal women found that shorter lifetime exposure to estrogen was associated with a higher risk of developing gout. This helps explain why global gout prevalence peaks about five years later in women (ages 65 to 69) than in men (ages 60 to 64). For women who never had gout before, the postmenopausal years represent a period of genuinely new risk.

Medications That Make Gout Worse

One of the more frustrating aspects of aging with gout is that medications prescribed for other common conditions can actively raise uric acid levels. Thiazide diuretics, a first-line treatment for high blood pressure, are a prime example. These drugs work partly by increasing uric acid reabsorption in the kidneys, effectively doing the opposite of what a gout patient needs.

In one study, 24.5% of patients on thiazide diuretics had elevated uric acid levels compared to 15.3% of those on other blood pressure medications. The risk grows with duration: among those who had been taking thiazides for more than four years, 46% were hyperuricemic. Data from the Framingham Heart Study showed that diuretic use was an independent risk factor for gout, associated with a 3.4 times higher risk in men and a 2.4 times higher risk in women. Loop diuretics, another type of water pill commonly used in older adults, carry similar or even higher risks. Combining loop and thiazide diuretics pushed the odds ratio for developing gout to 4.6.

Since high blood pressure, heart failure, and kidney disease all become more common with age, many older adults end up on one or more of these medications. If you have gout and are prescribed a diuretic, it’s worth discussing alternatives or additional monitoring with your doctor.

The Comorbidity Factor

Gout rarely exists in isolation, especially in older adults. It clusters with conditions like high blood pressure, diabetes, obesity, chronic kidney disease, and cardiovascular disease. These comorbidities don’t just coexist with gout; they feed into it. Kidney disease raises uric acid. Obesity increases uric acid production. Diabetes alters how the body processes purines. Each condition makes gout management harder, and gout itself appears to worsen cardiovascular and kidney outcomes in return.

This web of overlapping conditions also drives up costs. Healthcare spending for elderly gout patients is considerably higher than for younger patients, reflecting both the greater frequency of flares and the complexity of managing gout alongside other diseases.

Managing Gout as You Get Older

The good news is that gout progression is not inevitable. Current guidelines strongly recommend a treat-to-target approach, meaning your uric acid level should be regularly measured and your treatment adjusted to keep it below 6 mg/dL. Staying below this threshold allows existing crystals to slowly dissolve and prevents new ones from forming. This approach works at any age, though it requires consistent monitoring.

The practical challenge for older adults is that treatment choices can be more complicated. Kidney function, drug interactions, and other health conditions all narrow the options. Anti-inflammatory treatments commonly used for flares in younger patients may carry higher risks for older adults with heart or kidney problems. This doesn’t mean treatment isn’t possible; it means it requires more careful tailoring.

Lifestyle factors still matter at every age. Staying hydrated supports kidney function. Limiting alcohol, particularly beer, reduces uric acid production. Maintaining a healthy weight lowers both uric acid levels and the strain on affected joints. These measures won’t replace medication for most people with established gout, but they can meaningfully reduce flare frequency and slow progression alongside medical treatment.